The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
SOHO 2025 | The potential of preventive medicine in MDS
Matteo Della Porta, MD, IRCCS Humanitas Research Hospital, Milan, Italy, comments on the importance of preventive medicine in myelodysplastic syndromes (MDS), highlighting the potential for early clinical intervention in patients with clonal hematopoiesis. This interview took place at the 13th Annual Meeting of the Society of Hematologic Oncology (SOHO 2025) in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
